GLP-1 comparison

Mounjaro vs. Ozempic: how they compare for weight loss, blood sugar, side effects, and cost

Mounjaro and Ozempic are both once-weekly injections approved for type 2 diabetes, and both lead to weight loss. In the one large trial that compared them directly, people on Mounjaro lost more weight and lowered their A1C more than people on Ozempic 1 mg. Here is how the two differ, and what that means for choosing between them.

  • Different ingredients. Mounjaro is tirzepatide, which acts on GIP and GLP-1 receptors. Ozempic is semaglutide, which acts on GLP-1 only.
  • Mounjaro led to more weight loss in the head-to-head trial: 17 to 25 pounds, compared with about 13 pounds on Ozempic 1 mg.
  • Neither is approved for weight loss. Zepbound and Wegovy are the versions approved for weight management.

Last updated November 17, 2026. Sources are listed in the references.

Weight lost in the head-to-head trial

24.7 lbMounjaro 15 mg, 40 weeks

  • Mounjaro 10 mg20.5 lb
  • Mounjaro 5 mg16.8 lb
  • Ozempic 1 mg12.6 lb
  • A1C drop, Mounjaro vs. Ozempic2.0–2.3 vs. 1.9

SURPASS-2 trial in 1,879 adults with type 2 diabetes. Ozempic’s 2 mg dose was not tested. A1C change is in percentage points.

Mounjaro injection pens

Not sure which one fits? A licensed provider can review your health history and check what your insurance covers.

This page is for general information and is not medical advice. Prescription medications are only available after a licensed provider decides that treatment is appropriate for you. Prices and program terms are set by the manufacturers and pharmacies named and can change without notice.

Mounjaro vs. Ozempic: the key differences

The main difference is the active ingredient. Mounjaro contains tirzepatide, which activates two hormone receptors, GIP and GLP-1. Ozempic contains semaglutide, which activates GLP-1 only.1,2 That second target is the likely reason Mounjaro produced larger drops in weight and blood sugar in a direct comparison.3

MounjaroOzempic
Active ingredientTirzepatideSemaglutide
Made byEli LillyNovo Nordisk
How it worksActivates GIP and GLP-1 receptorsActivates the GLP-1 receptor
First FDA approval20222017
Approved forBlood sugar control in type 2 diabetes, ages 10 and up. Lowering the risk of heart attack, stroke, and cardiovascular death in adults with type 2 diabetes at high riskBlood sugar control in adults with type 2 diabetes. Lowering cardiovascular risk in adults with type 2 diabetes and heart disease. Slowing kidney disease in adults with type 2 diabetes and chronic kidney disease
Approved for weight loss?No. Zepbound is the tirzepatide brand for weight managementNo. Wegovy is the semaglutide brand for weight management
How oftenOnce a weekOnce a week (a daily Ozempic pill is also available)
Doses2.5, 5, 7.5, 10, 12.5, and 15 mg0.25, 0.5, 1, and 2 mg
DevicesSingle-dose pen, four-dose KwikPen, or vialMulti-dose pen with a dose dial
Self-pay priceFrom $499 a month$199 to $499 a month
With covered commercial insuranceAs little as $25 with Lilly’s savings cardAs little as $25 with Novo’s savings offer

Approved uses and doses are from each product’s prescribing information.1,2 Prices are from the manufacturers as of November 2026 and can change.4,5

Mounjaro vs. Ozempic for weight loss

Mounjaro led to more weight loss than Ozempic in the only large trial that compared the two directly. Keep in mind that neither medication is FDA-approved for weight loss. Both are approved for type 2 diabetes, and weight loss is an effect of treatment.1,2

The head-to-head trial: SURPASS-2

SURPASS-2 enrolled 1,879 adults with type 2 diabetes who were already taking metformin. They were assigned to Mounjaro 5 mg, 10 mg, or 15 mg, or to Ozempic 1 mg, for 40 weeks.3

GroupAverage weight lossA1C change
Mounjaro 5 mg16.8 lb (7.6 kg)−2.01 points
Mounjaro 10 mg20.5 lb (9.3 kg)−2.24 points
Mounjaro 15 mg24.7 lb (11.2 kg)−2.30 points
Ozempic 1 mg12.6 lb (5.7 kg)−1.86 points

Every Mounjaro dose beat Ozempic 1 mg on both measures. On average, people on Mounjaro lost between 4 and 12 pounds more than people on Ozempic, depending on dose.3

One limit of this trial. SURPASS-2 used Ozempic 1 mg. Ozempic’s highest dose, 2 mg, was approved later and wasn’t part of the comparison, so the gap at top doses may be smaller than these numbers suggest.

At weight-management doses, the pattern holds

A later trial, SURMOUNT-5, compared the same two ingredients at the doses used for weight management, in 751 adults with obesity who did not have diabetes. After 72 weeks, average weight loss was 20.2% with tirzepatide and 13.7% with semaglutide.6

Those are the doses sold as Zepbound and Wegovy, not Mounjaro and Ozempic. If your goal is weight management and you don’t have type 2 diabetes, those are the medications approved for it. See our Zepbound and Wegovy pages.

Why average results don’t predict yours

Trial averages hide a wide range. Some people respond strongly to semaglutide and less to tirzepatide, and the other way around. Dose, how long you stay on treatment, eating habits, activity, and whether you have diabetes all affect the result. People with type 2 diabetes tend to lose less weight on these medications than people without it.

Blood sugar, heart, and kidney benefits

Blood sugar

Both medications lower A1C substantially. In SURPASS-2, A1C fell by 2.01 to 2.30 percentage points with Mounjaro and by 1.86 points with Ozempic 1 mg, from a starting average of 8.28%.3 The difference was statistically significant at every Mounjaro dose, though both groups ended up with much better control.

Heart protection

Both now carry an FDA-approved use for lowering the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes. Ozempic’s applies to adults who have established heart disease. Mounjaro’s applies to adults at high risk for these events, and it was added to the label in 2026.1,2

Mounjaro’s approval is based on a trial of more than 13,000 adults in which it was compared with another GLP-1 medication, dulaglutide. Mounjaro was shown to be non-inferior for preventing major cardiovascular events. It was not shown to be superior.1

Kidney protection

Ozempic is also approved to reduce the risk of worsening kidney disease, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease.2 Mounjaro doesn’t have a kidney indication.

What this means in practice

  • If you have type 2 diabetes and chronic kidney disease, Ozempic has the specific approval.
  • If you have type 2 diabetes and heart disease, both have a cardiovascular indication, and your provider will weigh the details.
  • If the priority is the largest drop in A1C and weight, the head-to-head data favor Mounjaro.

Mounjaro vs. Ozempic side effects

The side effects are very similar. Both mainly cause stomach symptoms, such as nausea, diarrhea, and vomiting, that are most common while the dose is being increased.

In the head-to-head trial, rates were close:3

Side effectMounjaro (5–15 mg)Ozempic 1 mg
Nausea17–22%18%
Diarrhea13–16%12%
Vomiting6–10%8%
Serious adverse events (any)5–7%3%

Most stomach side effects in both groups were mild to moderate.3 Higher doses of either medication cause more of them.

Warnings they share

Both carry a boxed warning about thyroid C-cell tumors, and neither should be used by people with a personal or family history of medullary thyroid carcinoma or with MEN 2. Both labels also warn about pancreatitis, gallbladder problems, kidney injury from dehydration, low blood sugar when combined with insulin or a sulfonylurea, diabetic retinopathy complications, and severe stomach problems.1,2

One difference to know about

Mounjaro can make birth control pills less effective. Its label recommends switching to a non-oral method, or adding a barrier method, for four weeks after starting and for four weeks after each dose increase.1 Ozempic’s label doesn’t carry that recommendation.

For more detail, see Mounjaro side effects, Ozempic side effects, or our overview of GLP-1 side effects.

Mounjaro vs. Ozempic dosing

Both are injected under the skin once a week, on the same day each week, with or without food. Both start low and increase gradually, with at least four weeks at each step.1,2

MounjaroOzempic
Starting dose2.5 mg for 4 weeks0.25 mg for 4 weeks
Next step5 mg0.5 mg
Further increasesIn 2.5 mg steps, at least 4 weeks apart: 7.5, 10, 12.5, 15 mgTo 1 mg, then 2 mg, at least 4 weeks apart
Maximum dose15 mg a week (10 mg for ages 10 to 17)2 mg a week
Missed doseTake it within 4 days. After that, skip itTake it within 5 days. After that, skip it
Changing your injection dayAllowed if doses are at least 3 days apartAllowed if doses are at least 2 days apart
DeviceSingle-dose pen with a hidden needle, or a four-dose KwikPenOne pen holds several doses. You dial your dose and attach a new needle each time

The milligram numbers aren’t comparable between the two. A 5 mg dose of Mounjaro is not “stronger” than a 1 mg dose of Ozempic in any simple way, because they are different molecules.

Ozempic also comes as a once-daily pill in 1.5 mg, 4 mg, and 9 mg strengths, taken on an empty stomach with a small amount of water.7 Mounjaro is injection-only.

For step-by-step schedules, see our Ozempic dosage guide and the Mounjaro doses section.

Mounjaro vs. Ozempic cost

With commercial insurance that covers them, the two cost about the same: as little as $25 with the manufacturer’s savings program. Without coverage, Ozempic is usually cheaper, because Novo Nordisk lists lower self-pay prices.

Your situationMounjaroOzempic
Commercial insurance covers itAs little as $25 for a 1- to 3-month fill with the Mounjaro Savings CardAs little as $25 for up to a 3-month prescription with the Ozempic savings offer
Commercial insurance doesn’t cover itAs low as $499 for a one-month fill with the savings cardSelf-pay prices below
Paying cashFrom $499 a month through LillyDirect$199 a month for the first two fills on starter doses, then $349 a month. The 2 mg dose is $499
Medicare or MedicaidSavings card not available. Coverage depends on your planSavings offer not available. Coverage depends on your plan

Savings programs are run by Eli Lilly and Novo Nordisk, require a prescription for an FDA-approved use, and exclude government insurance. Terms as of November 2026.4,5

Insurance is the piece that decides most people’s cost. Plans generally cover Mounjaro and Ozempic for type 2 diabetes, often after prior authorization. They rarely cover either one when it is prescribed only for weight loss, because that use is off-label.

For full details, see the Mounjaro Savings Card and cost section and the Ozempic coupon and cost section.

If neither is covered

Roen providers can prescribe compounded tirzepatide ($329 a month, or $216 a month billed quarterly) or compounded semaglutide ($199 a month, or $106 a month on a 3-month supply) when appropriate. Compounded medications are not FDA-approved, and they are not the same as Mounjaro or Ozempic. See our tirzepatide and semaglutide pages.

Switching between Mounjaro and Ozempic

People switch for a few common reasons: a plateau, side effects, a change in insurance coverage, or supply. It should always be done with your provider, because there is no official dose-conversion chart between the two.

  • You don’t take both. They act on the same GLP-1 receptor, and they aren’t prescribed together.
  • Timing. A switch usually means taking your first dose of the new medication when the next dose of the old one would have been due.
  • Starting dose. Many providers start the new medication at a low dose and step up again, since tolerating one doesn’t guarantee you’ll tolerate the other at an equivalent strength.
  • Birth control. If you move from Ozempic to Mounjaro and take oral contraceptives, the four-week backup recommendation applies.1

Don’t use leftover pens from one medication to “bridge” to the other, and don’t change doses on your own.

Which is better, Mounjaro or Ozempic?

On average, Mounjaro lowers weight and A1C more. That doesn’t make it the better choice for everyone. The right one depends on your diagnosis, your other health conditions, what your insurance covers, and how you respond.

If this describes youWhat to discuss with a provider
Type 2 diabetes, and you want the largest drop in A1C and weightMounjaro had the edge in the head-to-head trial
Type 2 diabetes with chronic kidney diseaseOzempic has a specific kidney indication
You’d prefer not to injectOzempic is available as a daily pill
You take birth control pillsOzempic avoids the backup-contraception step that Mounjaro requires
Paying cashOzempic’s self-pay prices are lower
Weight management without diabetesZepbound or Wegovy, which are approved for it
Your plan covers only oneUsually the covered one, since the cost difference can be hundreds of dollars a month

How to get either one through Roen

You complete a health intake online, and a licensed provider reviews it. There is no appointment to schedule. If treatment is appropriate, your provider prescribes the medication that fits your health history, and we check your insurance coverage. Membership is $39 for the first month, then $135 a month, with medication billed separately.

Mounjaro vs. Ozempic FAQs

Is Mounjaro better than Ozempic for weight loss?

On average, yes. In the SURPASS-2 trial, adults with type 2 diabetes lost 16.8 to 24.7 pounds on Mounjaro over 40 weeks, compared with 12.6 pounds on Ozempic 1 mg. Individual results vary, and neither medication is FDA-approved for weight loss.

What is the difference between Mounjaro and Ozempic?

They contain different active ingredients. Mounjaro is tirzepatide, made by Eli Lilly, and acts on both GIP and GLP-1 receptors. Ozempic is semaglutide, made by Novo Nordisk, and acts on the GLP-1 receptor only. They also differ in doses, pen design, approved uses, and price.

Is Mounjaro stronger than Ozempic?

You can’t compare them milligram for milligram, because they are different molecules. In the head-to-head trial, every dose of Mounjaro lowered A1C and weight more than Ozempic 1 mg did. Ozempic’s 2 mg dose wasn’t tested in that trial.

Can you switch from Ozempic to Mounjaro?

Yes, with a provider’s guidance. There is no official dose conversion, so many providers start Mounjaro at a low dose and increase it step by step. You shouldn’t take both at the same time.

Can you take Mounjaro and Ozempic together?

No. Both act on the GLP-1 receptor, and they aren’t prescribed together.

Which has fewer side effects, Mounjaro or Ozempic?

They are similar. In the head-to-head trial, nausea affected 17% to 22% of people on Mounjaro and 18% on Ozempic, and diarrhea affected 13% to 16% and 12%. Side effects with either one are most common during dose increases.

Which is cheaper, Mounjaro or Ozempic?

With commercial insurance that covers them, both can cost as little as $25 with the manufacturer’s savings program. Paying cash, Ozempic is usually cheaper: $199 to $499 a month depending on dose, compared with $499 a month and up for Mounjaro. Prices are as of November 2026.

Are Mounjaro and Ozempic approved for weight loss?

No. Both are approved for type 2 diabetes. Zepbound contains the same ingredient as Mounjaro, and Wegovy contains the same ingredient as Ozempic. Those two are approved for weight management.

References
  1. Mounjaro (tirzepatide) Prescribing Information. Eli Lilly and Company. pi.lilly.com
  2. Ozempic (semaglutide) Prescribing Information. Novo Nordisk. novo-pi.com
  3. Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes (SURPASS-2). N Engl J Med. 2021;385(6):503–515. pubmed.ncbi.nlm.nih.gov/34170647
  4. Eli Lilly and Company. Mounjaro savings and resources, including Savings Card terms. mounjaro.lilly.com/savings-resources
  5. Novo Nordisk. Ozempic cost and coverage. ozempic.com
  6. Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26–36. pubmed.ncbi.nlm.nih.gov/40353578
  7. Ozempic (semaglutide) tablets Prescribing Information. Novo Nordisk. DailyMed. dailymed.nlm.nih.gov

Page last updated November 17, 2026.

Roen members

Get started on your GLP-1 weight loss plan today

  • Brand-name GLP-1s as low as $25 a month when your insurance covers them. Upload your card and we check coverage for you.*
  • Compounded options if you are not covered: semaglutide from $106 a month on a 3-month supply and tirzepatide from $216 a month on a quarterly plan.‡
  • No appointment needed. A licensed provider reviews your health history online and follows up by message, in all 50 states.
Licensed healthcare provider
Meet your care team

The right medication is the one that fits your health history

A licensed Roen provider reviews your diagnosis, your other conditions, and the medications you already take before recommending Mounjaro, Ozempic, or another option. We check your insurance, and your care team adjusts your dose as you go.

50 statesLicensed providers wherever you live
No appointmentA provider reviews your intake online and follows up by message
Mon–SunSupport 9am–8pm ET weekdays, 12–8pm ET weekends

Learn more about Roen weight loss

Real members, real support

50 statesRoen providers prescribe brand-name and compounded GLP-1s nationwide.
$25/moThe lowest monthly cost for brand-name medication when insurance covers it.*
$39Your first month of membership, with provider visits included.§

Individual experiences vary.

Roen member Susan
“Starting a new weight management program felt like a big decision. What I appreciated most was being able to talk openly about Zepbound and my concerns without feeling rushed.”
SusanRoen weight loss member
Roen member Danielle
“I was nervous about asking my provider about Mounjaro because I didn’t know where to start. They listened to my concerns and explained the next steps in plain language.”
DanielleRoen weight loss member
Roen member Marcus
“Talking about my weight hasn’t always been easy. When I asked about Wegovy, I felt comfortable being honest about my goals and concerns.”
MarcusRoen weight loss member
Roen member Priya
“I’d read so much about Ozempic that I wasn’t sure which questions to ask first. My provider helped me sort through everything and understand how my health history factored into the decision.”
PriyaRoen weight loss member
Roen member Daniel
“What I appreciated most was getting a clear explanation of what treatment with tirzepatide could involve. Having everything explained step by step helped me feel more prepared.”
DanielRoen weight loss member
Roen member Denise
“I sent my provider a whole list of questions about semaglutide. I left feeling heard and better informed about my choices.”
DeniseRoen weight loss member

A full range of GLP-1 weight loss medications

Roen providers prescribe both brand-name and compounded GLP-1s. Your provider helps you choose based on your health history, coverage, and budget.

Brand nameInsurance checked for you

Zepbound®

tirzepatide · weekly injection

Zepbound single-dose injection pens

As low as $25/mo if your insurance covers it*

Brand nameInsurance checked for you

Wegovy®

semaglutide · weekly injection

Wegovy injection pens in five dose strengths

As low as $25/mo if your insurance covers it*

Brand nameInsurance checked for you

Mounjaro®

tirzepatide · weekly injection

Mounjaro single-dose injection pens

As low as $25/mo if your insurance covers it*†

Brand nameInsurance checked for you

Ozempic®

semaglutide · weekly injection

Ozempic injection pens

As low as $25/mo if your insurance covers it*†

CompoundedCash-pay only

Compounded semaglutide

weekly injection · partner pharmacy

Roen compounded GLP-1 vial

$199/mo, or $106/mo on a 3-month supply‡

CompoundedCash-pay only

Compounded tirzepatide

weekly injection · partner pharmacy

Roen compounded GLP-1 vial

$329/mo, or $216/mo on a quarterly plan‡